Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03510234
Other study ID # 6954
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 23, 2018
Est. completion date February 2019

Study information

Verified date February 2018
Source University Hospital, Strasbourg, France
Contact David GAUCHER, MD, PhD
Phone 33 3 69 55 11 15
Email david.gaucher@chru-strasbourg.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To evaluate whether the use of the Argus II retinal prosthesis improves the confidence and self-esteem of patients with advanced retinopathy pigmentosa


Recruitment information / eligibility

Status Recruiting
Enrollment 18
Est. completion date February 2019
Est. primary completion date February 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Major patient (=18 years old)

- Patient already operated in France with artificial retina and having 1 year of follow-up

- Patient who has agreed to use his medical data for research purposes

Exclusion Criteria:

- Refusal to participate in the study

Study Design


Locations

Country Name City State
France Service D'Ophtalmologie Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Self-confidence Evaluation of Self-confidence via a questionnaire 12 months
See also
  Status Clinical Trial Phase
Completed NCT05179460 - A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopathy
Recruiting NCT04360291 - Impact of Visual Field Restriction on Visual Exploration
Recruiting NCT05643157 - Cellular Scale Measures of Short-Term Retinal Atrophy Progression
Recruiting NCT04419285 - Mobility Protocol Adapted for Advanced Visually Impaired Subjects N/A